BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37431844)

  • 21. COVID-19 in diabetic patients: Related risks and specifics of management.
    Orioli L; Hermans MP; Thissen JP; Maiter D; Vandeleene B; Yombi JC
    Ann Endocrinol (Paris); 2020 Jun; 81(2-3):101-109. PubMed ID: 32413342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential therapeutic effect of metformin in type 2 diabetic patients with severe COVID-19.
    Al-Kuraishy HM; Al-Gareeb AI; El Kholy AA; El-Khateeb E; Alexiou A; Papadakis M; Elekhnawy E; Alsubaie N; Hamad RS; Batiha GE
    Eur Rev Med Pharmacol Sci; 2023 Dec; 27(23):11445-11456. PubMed ID: 38095392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: A multicentral retrospective study.
    Cheng X; Xin S; Chen Y; Li L; Chen W; Li W; Zhou B; Li C; Gong Y; Li F; Duan P; Zhou X
    Life Sci; 2021 Jun; 275():119371. PubMed ID: 33745895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin and Covid-19: a systematic review of systematic reviews with meta-analysis.
    Petrelli F; Grappasonni I; Nguyen CTT; Tesauro M; Pantanetti P; Xhafa S; Cangelosi G
    Acta Biomed; 2023 Aug; 94(S3):e2023138. PubMed ID: 37695186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin use and mortality and length of stay among hospitalized patients with type 2 diabetes and COVID-19: A multiracial, multiethnic, urban observational study.
    Miao E; Zhang K; Liu J; Lin J; Yoo D; George CJ
    Front Endocrinol (Lausanne); 2022; 13():1002834. PubMed ID: 36440189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing.
    Varghese E; Samuel SM; Liskova A; Kubatka P; Büsselberg D
    PLoS Pathog; 2021 Jun; 17(6):e1009634. PubMed ID: 34157054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role.
    Samuel SM; Varghese E; Büsselberg D
    Trends Microbiol; 2021 Oct; 29(10):894-907. PubMed ID: 33785249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of Metformin.
    Al-Kuraishy HM; Al-Gareeb AI; Alblihed M; Cruz-Martins N; Batiha GE
    Front Med (Lausanne); 2021; 8():644295. PubMed ID: 33718411
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical features and risk factors for secondary hemophagocytic lymphohistiocytosis in elderly patients with severe SARS-CoV-2 infection: a multicenter retrospective cohort study].
    Deng Y; Lu S; Zhang G; Sun W; Chu Y; Meng M; Cui Y; Li P
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):793-799. PubMed ID: 37593855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin as a potential treatment for COVID-19.
    MCCarthy MW
    Expert Opin Pharmacother; 2023; 24(10):1199-1203. PubMed ID: 37194484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin-associated lactic acidosis and acute kidney injury in the era of COVID-19.
    Vordoni A; Theofilis P; Vlachopanos G; Koukoulaki M; Kalaitzidis RG
    Front Biosci (Schol Ed); 2021 Dec; 13(2):202-207. PubMed ID: 34879472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repurposing metformin for covid-19 complications in patients with type 2 diabetes and insulin resistance.
    Hashemi P; Pezeshki S
    Immunopharmacol Immunotoxicol; 2021 Jun; 43(3):265-270. PubMed ID: 34057870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comment on metformin and COVID-19 with regard to "Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID-19 patients with diabetes: A population-based study in Lombardy".
    Al-Salameh A; Wiernsperger N; Cariou B; Lalau JD
    Diabetes Obes Metab; 2022 Sep; 24(9):1888-1893. PubMed ID: 35545864
    [No Abstract]   [Full Text] [Related]  

  • 34. Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management.
    Vallianou NG; Evangelopoulos A; Kounatidis D; Stratigou T; Christodoulatos GS; Karampela I; Dalamaga M
    Curr Diabetes Rev; 2021; 17(6):e123120189797. PubMed ID: 33388022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin Treatment Is Associated with a Decreased Risk of Nonproliferative Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: A Population-Based Cohort Study.
    Fan YP; Wu CT; Lin JL; Hsiung CA; Liu HY; Lai JN; Yang CC
    J Diabetes Res; 2020; 2020():9161039. PubMed ID: 32377525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Efficacy and Potential Mechanisms of Metformin in the Treatment of COVID-19 in the Diabetics: A Systematic Review.
    Zangiabadian M; Nejadghaderi SA; Zahmatkesh MM; Hajikhani B; Mirsaeidi M; Nasiri MJ
    Front Endocrinol (Lausanne); 2021; 12():645194. PubMed ID: 33815295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association Between Anti-diabetic Agents and Clinical Outcomes of COVID-19 in Patients with Diabetes: A Systematic Review and Meta-Analysis.
    Han T; Ma S; Sun C; Zhang H; Qu G; Chen Y; Cheng C; Chen EL; Ayaz Ahmed M; Kim KY; Manem R; Chen M; Guo Z; Yang H; Yan Y; Zhou Q
    Arch Med Res; 2022 Feb; 53(2):186-195. PubMed ID: 34412904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Hepcidin levels in Type 2 Diabetes Mellitus treated with metformin or combined anti-diabetic agents in Pakistani population.
    Najeeb T; Soomro Late MS; Fawwad A; Waris N; Nangrejo R; Siddiqui IA; Aziz Q; Basit A
    J Pak Med Assoc; 2023 Feb; 73(2):313-318. PubMed ID: 36800717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Comorbid Diabetes on Clinical Characteristics of COVID-19 Patients Infected by the Wild-Type or Delta Variant of SARS-CoV-2.
    Zhang J; Zhang J; Tao Z
    Front Endocrinol (Lausanne); 2022; 13():861443. PubMed ID: 35600601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comorbidities and laboratory parameters associated with SARS-CoV-2 infection severity in patients from the southeast of Mexico: a cross-sectional study.
    De la Cruz-Cano E; Jiménez-González CDC; Díaz-Gandarilla JA; López-Victorio CJ; Escobar-Ramírez A; Uribe-López SA; Huerta-García E; Ayala-Sumuano JT; Morales-García V; Gútierrez-López L; González-Garrido JA
    F1000Res; 2022; 11():10. PubMed ID: 35464048
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.